Staphylococcus aureus is an important opportunistic Gram-positive bacterial pathogen that can cause a variety of both hospital- and community-acquired infections in humans. The recent emergence of strains that are resistant to all antibiotics in use, including the last ‘magic bullet’ vancomycin, coupled with the lack of an effective anti-staphylococcal vaccine, has made this pathogen a major health concern. Thus, a better understanding of the biology and pathogenicity of S. aureus is crucial for the discovery of novel targets for antimicrobial agent and vaccine development. With this in mind, the recent publication of the whole genome sequences of two related methicillin-resistant strains of S. aureus (N315 and Mu50) by Kuroda et al.1xWhole genome sequencing of methicillin-resistant Staphylococcus aureus. Kuroda, M. et al. Lancet. 2001; 357: 1225–1240Abstract | Full Text | Full Text PDF | PubMed | Scopus (1140)See all References1 has been hailed with much enthusiasm.The circular chromosomes of strains N315 and Mu50 are ∼2.8 Mb in size, have a low G+C content (∼33%), and are predicted to contain 2595 and 2697 ORFs, respectively. The nucleotide sequences of the two genomes are 96% identical, most of the differences being caused by the presence of Mu50-specific mobile genetic elements. S. aureus is grouped with Bacillus spp. on the basis of rRNA sequence. Consistent with this, up to 52% of the predicted proteins of N315 are most similar to those from B. subtilis and Bacillus halodurans. These proteins are mostly involved in essential cellular functions. The remaining predicted proteins are encoded by a complex mixture of genes, many of which might have been acquired by lateral gene transfer.The N315 and Mu50 genomes both contain numerous mobile genetic elements, including insertion sequence (IS) elements, transposons, prophages and pathogenicity islands. Many of these elements carry drug resistance and other virulence determinants (such as toxin genes), having important implications for the lateral spread of these factors. Indeed, the plasticity of the S. aureus genome is crucial for the ability of this pathogen to adapt and respond to the selective pressures of its environment.A future challenge lies in the dissection of the molecular basis of high β-lactam resistance and vancomycin resistance in S. aureus. N315 and Mu50 contain a virtually identical mobile staphylococcal cassette chromosome mec (SCCmec) element that encodes resistance to β-lactams and several other antibiotics. N315 exhibits only low-level β-lactam resistance, whereas Mu50 exhibits high-level β-lactam and vancomycin resistance. However, it is possible to isolate N315 derivatives with high-level β-lactam or vancomycin resistance in vitro using a two-step selection process. Given the genetic relatedness of N315 and Mu50, a detailed comparison of the genome sequences of these strains, coupled with gene expression studies, should shed light on the molecular mechanisms responsible for these conversions.Genes encoding almost all of the previously identified virulence factors of S. aureus are present in both genomes. Furthermore, 70 new putative virulence factors were identified, highlighting the remarkable pathogenic potential of this bacterium. As many as 18 predicted proteins were identified that contain a carboxy-terminal LPXTG motif, typical of many cell wall-anchored proteins of Gram-positive bacteria. Of these, seven are previously identified adhesins. In addition, the genes encoding 22 putative exoenzymes, six of which are new candidates, were identified. Interestingly, both N315 and Mu50 appear to have the capability to produce numerous proteins that target the host immune response. These include an impressive array of secreted exotoxins and enterotoxins with superantigen activity, the genes for which are clustered into three pathogenicity islands. Furthermore, genes encoding four MHC class II β-chain analogues were also identified. Three of these predicted proteins are similar to the previously identified Map protein of S. aureus, which binds to a variety of host extracellular matrix molecules and which might also have immunomodulatory activity.